Journal 2020 Vol.21 No.2

Guidelines
Interim Guidelines on the Screening, Assessment and Clinical Management of Pediatric Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19)
Maria Carmen B. Nievera, M.D., Cecilia C. Maramba-Lazarte, M.D. ,Anna Lisa T. Ong-Lim, M.D., John Andrew T. Camposano, M.D, Ma. Liza Antoinette M. Gonzales, M.D., Francesca Mae T. Pantig, M.D, Paul Sherwin O. Tarnate, M.D., Lesley Anne C. Dela Cruz, M.D, Imelda A. Luna, M.D., Jay Ron O. Padua, M.D, Abigail C. Rivera, M.D. & Ma. Kristina Ulob-Torio, M.D.

Introduction
The emergence of the novel coronavirus SARSCoV-2 and the subsequent declaration by the World Health Organization of the coronavirus disease 2019 (COVID-19) pandemic has greatly impacted the lives of many all over the world. As the total number of reported cases increase globally, the number of pediatric cases have also steadily increased over the past several months. This has led to an expansion of the wealth of scientific and clinical knowledge on COVID-19 in children.
This rapid advice has been updated from the previous version (version 2, released 12 April 2020) as new knowledge on pediatric COVID-19 has become available in recent literature. It aims to provide guidance to pediatricians, general and family practitioners, and other healthcare professionals caring for children on how to assess and treat pediatric patients with suspected or confirmed COVID-19. These guidelines were
formulated based on information available at the time of its release, and shall be updated as new data becomes available.
https://doi.org/10.56964/pidspj20202102009
| View Full Article in PDF format |